These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3314698)

  • 1. Cefotaxime stability during in vitro microbiological testing.
    Marchbanks CR; Yost RL; White RL
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1375-8. PubMed ID: 3314698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
    Neu HC
    Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro studies on cefotaxime and desacetylcefotaxime.
    Selwyn S; Bakhtiar M
    Drugs Exp Clin Res; 1986; 12(12):953-65. PubMed ID: 3494587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antibacterial activity of cefmetazole and other antibiotics to 463 isolates].
    Xu Y; Wang H; Chen M
    Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):540-2. PubMed ID: 10436961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.
    Stevens DL; Bergstrom R; Gibbons A
    Diagn Microbiol Infect Dis; 1989; 12(1):73-80. PubMed ID: 2653715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of cefotaxime, desacetylcefotaxime, and the combination of the two.
    Friis H
    Diagn Microbiol Infect Dis; 1989; 12(1):67-72. PubMed ID: 2714074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
    Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
    Jones RN; Barry AL; Thornsberry C
    Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R; Nightingale CH; Tilton R
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin.
    Scully BE; Jules K; Neu HC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):907-13. PubMed ID: 6311090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
    Piédrola G; Galan I; Leyva A; Maroto MC
    Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
    Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
    J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
    Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
    Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.
    Jones RN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():39-43. PubMed ID: 6094461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of the dual-action cephalosporin Ro 23-9424.
    Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symposium: new findings on the antibacterial interactions between cefotaxime and desacetylcefotaxime.
    Diagn Microbiol Infect Dis; 1989; 12(1):23-121. PubMed ID: 2714069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.